litlas
ログインアカウント作成

Björn Dahlöf

1990–2026 年に発表

128
論文数
62,275
被引用数
100
h 指数
128
i10 指数

被引用数

Björn Dahlöf の年別被引用数1980 年: 被引用 1 件1985 年: 被引用 1 件1986 年: 被引用 1 件1988 年: 被引用 1 件1989 年: 被引用 2 件1991 年: 被引用 1 件1992 年: 被引用 8 件1993 年: 被引用 18 件1994 年: 被引用 18 件1995 年: 被引用 18 件1996 年: 被引用 30 件1997 年: 被引用 31 件1998 年: 被引用 64 件1999 年: 被引用 84 件2000 年: 被引用 146 件2001 年: 被引用 222 件2002 年: 被引用 281 件2003 年: 被引用 406 件2004 年: 被引用 582 件2005 年: 被引用 540 件2006 年: 被引用 534 件2007 年: 被引用 499 件2008 年: 被引用 424 件2009 年: 被引用 377 件2010 年: 被引用 439 件2011 年: 被引用 553 件2012 年: 被引用 541 件2013 年: 被引用 566 件2014 年: 被引用 494 件2015 年: 被引用 406 件2016 年: 被引用 363 件2017 年: 被引用 342 件2018 年: 被引用 275 件2019 年: 被引用 807 件2020 年: 被引用 679 件2021 年: 被引用 580 件2022 年: 被引用 505 件2023 年: 被引用 379 件2024 年: 被引用 527 件2025 年: 被引用 216 件2026 年: 被引用 29 件1981〜1984 年は被引用が無いため表示していません1987 年は被引用が無いため表示していません1990 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,287 件、この内訳の 22.5%イギリス: 引用元論文 1,342 件、この内訳の 9.2%イタリア: 引用元論文 986 件、この内訳の 6.7%ドイツ: 引用元論文 724 件、この内訳の 4.9%中国: 引用元論文 641 件、この内訳の 4.4%カナダ: 引用元論文 614 件、この内訳の 4.2%オーストラリア: 引用元論文 573 件、この内訳の 3.9%オランダ: 引用元論文 531 件、この内訳の 3.6%日本: 引用元論文 476 件、この内訳の 3.3%スウェーデン: 引用元論文 454 件、この内訳の 3.1%フランス: 引用元論文 451 件、この内訳の 3.1%スペイン: 引用元論文 371 件、この内訳の 2.5%
0%22.5%その他 28.6%

機関

分野

  • Medicine89.4%
  • Biochemistry, Genetics and Molecular Biology4.2%
  • Neuroscience1.3%
  • Immunology and Microbiology0.8%
  • Nursing0.8%
  • Health Professions0.7%
  • その他2.8%

トピック

  • Blood Pressure and Hypertension Studies9.9%
  • Atrial Fibrillation Management and Outcomes4.8%
  • Lipoproteins and Cardiovascular Health4.4%
  • Diabetes, Cardiovascular Risks, and Lipoproteins3%
  • Hormonal Regulation and Hypertension2.9%
  • Cardiovascular Function and Risk Factors2.8%
  • その他72.2%

共著者

全論文

検索で開く
  1. Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials

    著者: Jane Armitage, Colin Baigent, Elizabeth H Barnes, D. J. Betteridge, Lisa Blackwell, Michael A. Blazing, Louise Bowman, Eugene Braunwald, Robert Byington, Christopher P. Cannon, Michael Clearfield, Helen M. Colhoun, Rory Collins, Björn Dahlöf, Kelly Davies, Barry R. Davis, James A. de Lemos, John R. Downs, Paul N. Durrington, Jonathan Emberson, Bengt Fellström, Marcus Flather, Ian Ford, Maria Grazia Franzosi, Jordan Fulcher, John A. Fuller, Curt D. Furberg, David Gordon, Shinya Goto, Antonio M. Gotto, Heather Halls, Charlie Harper, C. Hawkins, William G. Herrington, G. A. Hitman, Hallvard Holdaas, Lisa Holland, Alan G. Jardine, J. Wouter Jukema, John J.P. Kastelein, Sharon Kean, Anthony Keech, Adrienne Kirby, John Kjekshus, Genell L. Knatterud, Robert H. Knopp, Wolfgang Köenig, Michael J. Koren, Vera Krane, Martin Landray, John C. LaRosa, Eva Lonn, Peter W. Macfarlane, Stephen MacMahon, Aldo P. Maggioni, Roberto Marchioli, Ian C. Marschner, Borislava Mihaylova, Lemuel A. Moyé, Sabina A. Murphy, Haruo Nakamura, Andrew Neil, Connie B. Newman, Rachel O’Connell, Chris J. Packard, Sarah Parish, Terje Pedersen, Richard Peto, Marc A. Pfeffer, Neil Poulter, David Preiss, Christina Reith, Paul M. Ridker, Michele Robertson, Frank M. Sacks, Naveed Sattar, Roland E. Schmieder, Patrick W. Serruys, Peter Sever, John Shaw, Charles L. Shear, John Simes, Peter Sleight, Enti Spata, Luigi Tavazzi, Jonathan A. Tobert, Gianni Tognoni, Andrew Tonkin, Stella Trompet, George Varigos, Christoph Wanner, Hans Wedel, Harvey D. White, John Wikstrand, Lars Wilhelmsen, Kate Wilson, Robin Young, Salim Yusuf, Faı̈ez Zannad - The Lancet 2019 被引用: 791

  2. Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials

    著者: Christina Reith, Colin Baigent, Lisa Blackwell, Jonathan Emberson, Enti Spata, Kelly Davies, Heather Halls, Lisa Holland, Kate Wilson, Jane Armitage, Charlie Harper, David Preiss, Alistair Roddick, Anthony Keech, John Simes, Rory Collins, Elizabeth H Barnes, Jordan Fulcher, William G. Herrington, Adrienne Kirby, Borislava Mihaylova, Rachel O’Connell, Pierre Amarenco, Philip J. Barter, D. J. Betteridge, Michael A. Blazing, Jackie Bosch, Louise Bowman, Eugene Braunwald, Christopher P. Cannon, Michael Clearfield, Stuart M. Cobbe, Helen M. Colhoun, Björn Dahlöf, Barry R. Davis, James A. de Lemos, John R. Downs, Paul N. Durrington, Bengt Fellström, Ian Ford, Maria Grazia Franzosi, John A. Fuller, Curt D. Furberg, Robert J. Glynn, David Gordon, Antonio M. Gotto, Richard H. Grimm, Ajay Gupta, C. Hawkins, G. A. Hitman, Hallvard Holdaas, Alan G. Jardine, J. Wouter Jukema, John J.P. Kastelein, Sharon Kean, John Kjekshus, Genell L. Knatterud, Robert H. Knopp, Wolfgang Köenig, Michael J. Koren, Vera Krane, Martin Landray, John C. LaRosa, Roberto Latini, Eva Lonn, Donata Lucci, Jean MacFadyen, Peter W. Macfarlane, Stephen MacMahon, Aldo P. Maggioni, Roberto Marchioli, Ian C. Marschner, Lemuel A. Moyé, Sabina A. Murphy, Andrew Neil, Enrico Nicolis, Chris J. Packard, Sarah Parish, Terje R. Pedersen, Richard Peto, Marc A. Pfeffer, Neil R Poulter, Sara Pressel, Jeffrey L. Probstfield, Mahboob Rahman, Paul M. Ridker, Michele Robertson, Frank M. Sacks, Naveed Sattar, Roland E. Schmieder, Patrick W. Serruys, Peter Sever, John Shaw, James Shepherd, Lara M. Simpson, Peter Sleight, Luigi Tavazzi, Gianni Tognoni, Andrew Tonkin, Stella Trompet ほか 28 名 - The Lancet 2022 被引用: 246

  3. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

    著者: Peter Sever, Björn Dahlöf, Neil R Poulter, Hans Wedel, Gareth Beevers, Mark J. Caulfield, Rory Collins, Sverre E. Kjeldsen, Arni Kristinsson, Gordon T. McInnes, Jesper Mehlsen, Markku S. Nieminen, Eoin OʼBrien, Jan Östergren - The Lancet 2003 被引用: 3,792

  4. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension

    著者: Peter M. Rothwell, Sally C. Howard, Eamon Dolan, Eoin OʼBrien, Joanna E Dobson, Björn Dahlöf, Peter Sever, Neil R Poulter - The Lancet 2010 被引用: 1,779

  5. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

    著者: Authors/Task Force Members, A. John Camm, Paulus Kirchhof, Gregory Y.H. Lip, Ulrich Schotten, Irene Savelieva, Sabine Ernst, Isabelle C. Van Gelder, Nawwar Al‐Attar, Gerhard Hindricks, Bernard Prendergast, Hein Heidbüchel, Ottavio Alfieri, Annalisa Angelini, Dan Atar, Paolo Colonna, Raffaele De Caterina, Johan De Sutter, Andreas Goette, Bülent Görenek, Magnus Heldal, Stefan H. Hohloser, Philippe Kolh, J.‐Y. Le Heuzey, Piotr Ponikowski, Frans H. Rutten, Alec Vahanian, Angelo Auricchio, Jeroen J. Bax, Claudio Ceconi, V. Dean, Gerasimos Filippatos, Christian Funck‐Brentano, Richard Hobbs, Patricia M. Kearney, Theresa A. McDonagh, Bogdan A. Popescu, Željko Reiner, Udo Sechtem, Per Anton Sirnes, Michał Tendera, P. E. Vardas, Petr Widimský, Document Reviewers, P. E. Vardas, Vazha Agladze, E Aliot, T. Balabanski, Carina Blomström‐Lundqvist, Alessandro Capucci, Harry J.G.M. Crijns, Björn Dahlöf, Thierry Folliguet, Michael Glikson, Marnix Goethals, Dietrich C. Gulba, Siew Yen Ho, Robert J.M. Klautz, Sedat Köse, John J.V. McMurray, Pasquale Perrone Filardi, Pekka Raatikainen, M. J. Salvador, Martin J. Schalij, A. Shpektor, João de Sousa, Janina Stępińska, Hasso Uuetoa, José Luis Zamorano, Igor Zupan - European Heart Journal 2010 被引用: 5,873

  6. Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis

    著者: Christina Reith, David Preiss, Lisa Blackwell, Jonathan Emberson, Enti Spata, Kelly Davies, Heather Halls, Charlie Harper, Lisa Holland, Kate Wilson, Alistair Roddick, Christopher P. Cannon, Robert Clarke, Helen M. Colhoun, Paul N. Durrington, Shinya Goto, G. A. Hitman, G. Kees Hovingh, J. Wouter Jukema, Wolfgang Köenig, Ian C. Marschner, Borislava Mihaylova, Connie B. Newman, Jeffrey L Probsfield, Paul M. Ridker, Marc S. Sabatine, Naveed Sattar, Gregory G. Schwartz, Luigi Tavazzi, Andrew Tonkin, Stella Trompet, Harvey D. White, Salim Yusuf, Jane Armitage, Anthony Keech, John Simes, Rory Collins, Colin Baigent, Elizabeth H Barnes, Jordan Fulcher, William G. Herrington, Adrienne Kirby, Rachel O’Connell, Pierre Amarenco, Hiroyuki Arashi, Philip J. Barter, D. J. Betteridge, Michael A. Blazing, Gerard J Blauw, Jackie Bosch, Louise Bowman, Eugene Braunwald, Richard Bulbulia, Robert Byington, Michael Clearfield, Stuart M. Cobbe, Björn Dahlöf, Barry R. Davis, James A. de Lemos, John R. Downs, Bengt Fellström, Marcus Flather, Ian Ford, Maria Grazia Franzosi, John A. Fuller, Curt D. Furberg, Robert J. Glynn, Uri Goldbourt, David Gordon, Antonio M. Gotto, Richard Grimm, A Gupta, C. Hawkins, Richard Haynes, Hallvard Holdaas, Jemma C. Hopewell, Alan G. Jardine, John J.P. Kastelein, Sharon Kean, Patricia M. Kearney, George D. Kitas, John Kjekshus, Genell L. Knatterud, Robert H. Knopp, Michael J. Koren, Vera Krane, Martin Landray, John C. LaRosa, Roberto Latini, Eva Lonn, Donata Lucci, Jean MacFadyen, Peter W. Macfarlane, Stephen MacMahon, Aldo P. Maggioni, Roberto Marchioli, Lemuel A. Moyé, Sabina A. Murphy, Andrew Neil, Enrico Nicolis ほか 32 名 - The Lancet Diabetes & Endocrinology 2024 被引用: 137

  7. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial

    著者: Björn Dahlöf, Peter Sever, Neil R Poulter, Hans Wedel, DG Beevers, Mark J. Caulfield, Rory Collins, Sverre E. Kjeldsen, Arni Kristinsson, Gordon T. McInnes, Jesper Mehlsen, Markku S. Nieminen, Eoin OʼBrien, Jan Östergren - The Lancet 2005 被引用: 2,918

  8. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial

    著者: Lennart Hansson, Alberto Zanchetti, S. George Carruthers, Björn Dahlöf, Dag Elmfeldt, Stevo Julius, Joël Ménard, K. H. Rahn, Hans Wedel, S. Westerling - The Lancet 1998 被引用: 5,781

  9. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

    著者: Björn Dahlöf, Richard B. Devereux, Sverre E. Kjeldsen, Stevo Julius, Gareth Beevers, Ulf dé Fairé, Frej Fyhrquist, Hans Ibsen, Krister Kristiansson, Ole Lederballe‐Pedersen, Lars Lindholm, Markku S. Nieminen, Per Omvik, Suzanne Oparil, Hans Wedel - The Lancet 2002 被引用: 5,417

  10. Cardiovascular Disease Risk Factors: Epidemiology and Risk Assessment

    著者: Björn Dahlöf - The American Journal of Cardiology 2009 被引用: 356

  11. Effects of β blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke

    著者: Peter M. Rothwell, Sally C. Howard, Eamon Dolan, Eoin OʼBrien, Joanna E Dobson, Björn Dahlöf, Neil R Poulter, Peter Sever - The Lancet Neurology 2010 被引用: 687

  12. Prospective Randomized Open Blinded End-point (PROBE) Study. A novel design for intervention trials

    著者: Lennart Hansson, Thomas Hedner, Björn Dahlöf - Blood Pressure 1992 被引用: 575

  13. Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events

    著者: Salim Yusuf, Hans‐Christoph Diener, Ralph L. Sacco, Daniel Cotton, Stephanie Ôunpuu, William A Lawton, Yuko Palesch, Renée H. Martin, Gregory W. Albers, Philip M. Bath, Natan M. Bornstein, Bernard P.L. Chan, Sien-Tsong Chen, Luı́s Cunha, Björn Dahlöf, Jacques De Keyser, Geoffrey A. Donnan, Conrado J. Estol, Philip B. Gorelick, Vivian Gu, Karin Hermansson, Lutz Hilbrich, Markku Kaste, Chuanzhen Lü, Thomas Machnig, Prem Pais, Robin Roberts, Veronika Skvortsova, Philip Teal, Danilo Toni, Cam P. VanderMaelen, Thor Voigt, Michael A. Weber, Byung‐Woo Yoon - New England Journal of Medicine 2008 被引用: 781

  14. Infrared Laser Therapy for Ischemic Stroke: A New Treatment Strategy

    著者: Yair Lampl, Justin A. Zivin, Marc Fisher, Robert Lew, Lennart Welin, Björn Dahlöf, Peter Borenstein, Björn Andersson, Julio E. Pérez, César Caparó, Sanja Ilic, Uri Oron - Stroke 2007 被引用: 385

  15. Physical activity and exercise lower blood pressure in individuals with hypertension: narrative review of 27 RCTs

    著者: Mats Börjesson, Aron Onerup, Stefan Lundqvist, Björn Dahlöf - British Journal of Sports Medicine 2016 被引用: 350

  16. Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase

    著者: Ajay Gupta, David Thompson, Andrew Whitehouse, Timothy Collier, Björn Dahlöf, Neil R Poulter, Rory Collins, Peter Sever - The Lancet 2017 被引用: 342

  17. Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients

    著者: Kenneth Jamerson, Michael A. Weber, George L. Bakris, Björn Dahlöf, Bertram Pitt, Victor Shi, Allen Hester, Jitendra Gupte, Marjorie Gatlin, Eric J. Velazquez - New England Journal of Medicine 2008 被引用: 2,074

  18. Effectiveness and Safety of Transcranial Laser Therapy for Acute Ischemic Stroke

    著者: Justin A. Zivin, Gregory W. Albers, Natan M. Bornstein, Thomas J. Chippendale, Björn Dahlöf, Thomas Devlin, Marc Fisher, Werner Hacke, William L. Holt, Sanja Ilic, Scott E. Kasner, Robert Lew, Marshall Nash, Julio E. Pérez, Marilyn M. Rymer, Peter D. Schellinger, Dietmar Schneider, Stefan Schwab, Roland Veltkamp, Michael G. Walker, Jackson Streeter - Stroke 2009 被引用: 289

  19. Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke

    著者: Ralph L. Sacco, Hans‐Christoph Diener, Salim Yusuf, Daniel Cotton, Stephanie Ôunpuu, William A Lawton, Yuko Palesch, Renée H. Martin, Gregory W. Albers, Philip M. Bath, Natan M. Bornstein, Bernard P.L. Chan, Sien-Tsong Chen, Luı́s Cunha, Björn Dahlöf, Jacques De Keyser, Geoffrey A. Donnan, Conrado J. Estol, Philip B. Gorelick, Vivian Gu, Karin Hermansson, Lutz Hilbrich, Markku Kaste, Chuanzhen Lü, Thomas Machnig, Prem Pais, Robin Roberts, Veronika Skvortsova, Philip Teal, Danilo Toni, Cam P. VanderMaelen, Thor Voigt, Michael A. Weber, Byung‐Woo Yoon - New England Journal of Medicine 2008 被引用: 966

  20. Transcranial Laser Therapy in Acute Stroke Treatment

    著者: Werner Hacke, Peter D. Schellinger, Gregory W. Albers, Natan M. Bornstein, Björn Dahlöf, Rachael L. Fulton, Scott E. Kasner, Ashfaq Shuaib, Steven P. Richieri, Stephen Dilly, Justin A. Zivin, Kennedy R. Lees, Joseph P. Broderick, Anastasia Ivanova, Karen C. Johnston, Bo Norrving, Andrei V. Alexandrov, David M. Brown, Patrick M. Capone, David Chiu, Wayne M. Clark, Jack Cochran, Colin Deredyn, Thomas Devlin, William Hickling, George Howell, David Huang, Shazam Hussain, Sidney Mallenbaum, Majaz Moonis, Marshall Nash, Marilyn M. Rymer, Reid Taylor, Margaret Tremwel, Brian Buck, Julio E. Pérez, Christian Gerloff, Bernd Greiwing, Martin Grond, Gerhard Hamman, Thomas Haarmeiter, Sebastian Jander, Martin Köhrmann, Martin Ritter, Dietmar Schneider, Jan Sobesky, Thorsten Steiner, Helmuth Steinmetz, Roland Veltkamp, Christian Weimar, Franz Gruber, Björn Andersson, Lennart Welin, Didier Leys, Turgut Tatlisumak, Andreas R. Luft, Philippe Lyrer, Patrik Michel, Carlos A. Molina, Tomás Segura - Stroke 2014 被引用: 124

  21. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol

    著者: Kristian Wachtell, Mika Lehto, Eva Gerdts, Michael Hecht Olsen, Björn Hornestam, Björn Dahlöf, Hans Ibsen, Stevo Julius, Sverre E. Kjeldsen, Lars Lindholm, Markku S. Nieminen, Richard B. Devereux - Journal of the American College of Cardiology 2005 被引用: 827

  22. Effect of Spironolactone on Blood Pressure in Subjects With Resistant Hypertension

    著者: Neil Chapman, Joanna Dobson, Sarah L Wilson, Björn Dahlöf, Peter Sever, Hans Wedel, Neil R Poulter - Hypertension 2007 被引用: 624

  23. The impact of serum uric acid on cardiovascular outcomes in the LIFE study

    著者: Aud Høieggen, Michael H. Alderman, Sverre E. Kjeldsen, Stevo Julius, Richard B. Devereux, Ulf de Faire, Frej Fyhrquist, Hans Ibsen, Krister Kristianson, Ole Lederballe‐Pedersen, Lars Lindholm, Markku S. Nieminen, Per Omvik, Suzanne Oparil, Hans Wedel, Cong Chen, Björn Dahlöf, for the LIFE Study Group - Kidney International 2004 被引用: 476

  24. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study

    著者: Hans‐Christoph Diener, Ralph L. Sacco, Salim Yusuf, Daniel Cotton, Stephanie Ôunpuu, William A Lawton, Yuko Palesch, Renée H. Martin, Gregory W. Albers, Philip M. Bath, Natan M. Bornstein, Bernard PL Chan, Sien-Tsong Chen, Luı́s Cunha, Björn Dahlöf, Jacques De Keyser, Geoffrey A. Donnan, Conrado J. Estol, Philip B. Gorelick, Vivian Gu, Karin Hermansson, Lutz Hilbrich, Markku Kaste, Chuanzhen Lü, Thomas Machnig, Prem Pais, Robin Roberts, Veronika Skvortsova, Philip Teal, Danilo Toni, Cam P. VanderMaelen, Thor Voigt, Michael A. Weber, Byung‐Woo Yoon - The Lancet Neurology 2008 被引用: 357